Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral
Levy, G.A.
Transplantation Proceedings 28(4): 2252-2253
1996
ISSN/ISBN: 0041-1345 PMID: 8769216 Document Number: 458139
Document emailed within 1 workday
Related Documents
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233Atkison, P.R.; Grant, D.R.; Williams, S.E.; Howard, J.; Wall, W.J.; Stiller, C.R. 1994: Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin a Transplantation Proceedings 26(5): 2953-2954
Roth, D.; Miller, J. 1996: Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients Transplantation Proceedings 28(4): 2219
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Tsang, W.K.; Ho, Y.W.; Tong, K.L.; Chan, W.H.; Chan, A. 1996: Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients Transplantation Proceedings 28(3): 1330-1332
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315
McCauley, J.; Fung, J.J.; Brown, H.; Deballi, P.; Jain, A.; Todo, S.; Starzl, T.E. 1991: Renal function after conversion from cyclosporine to FK 506 in liver transplant patients Transplantation Proceedings 23(6): 3148-3149
Graziadei, I.W.; Wiesner, R.H.; Marotta, P.J.; Porayko, M.K.; Dahlke, L.J.; Wilson, S.M.; Steers, J.L.; Krom, R.A. 1997: Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation Transplantation 64(5): 726-731
Pethig, K.; Geiger, M.; Korn, A.; Grote, M.; Christians, U.; Wahlers, T. 1996: Follow-up after conversion to Neoral in stable heart transplant recipients Transplantation Proceedings 28(4): 2282-2284
Browne, B.J.; Jordan, S.; Welsh, M.S.; Van Buren, C.; Kahan, B.D. 1994: Diet and cyclosporin A--pharmacokinetic comparison between Neoral and Sandimmune gelatin capsules Transplantation Proceedings 26(5): 2959-2960
Neumayer, H.H.; Budde, K.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J.; Luft, F.C. 1996: Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year Clinical Nephrology 45(5): 326-331
Färber, L.; Maibücher, A.; Geissler, F.; Gutzler, F.; Wiesinger, F.O.; Winkler, M. 1994: Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients Transplantation Proceedings 26(5): 2988-2993
Odone, P.; Iberti, M. 1999: Switching to Neoral in patients with a stable kidney transplant. Retrospective study Minerva Urologica e Nefrologica 51(2): 79-83
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Massari, P.U.; Grosso, S.; de Boccardo, G.; Vásquez, M.C.; Schiavelli, R.O.; Sabbatiello, R.R.; Casadei, D.H.; Rial, M.C.; Jost, L.J.; Túrin, M.D.; Agost Carreño C, A.; Maggiora, E.C.; Gadea, M.M. 1996: A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group Transplantation Proceedings 28(6): 3365-3367
Borel, J.F. 1988: Immunosuppression: building on Sandimmune (cyclosporine) Transplantation Proceedings 20(1 Suppl 1: 149-153
Laine, J.; Hoppu, K.; Jalanko, H.; Rönnholm, K.; Holmberg, C. 1997: Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allografts Transplantation 63(12): 1768-1772
Fung, J.J.; Todo, S.; Tzakis, A.; Demetris, A.; Jain, A.; Abu-Elmaged, K.; Alessiani, M.; Starzl, T.E. 1991: Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls Transplantation Proceedings 23(1 Part 1): 14-21
Palmiero, G.; Ciampi, R.; Gallo, R.; Federico, S.; Sabbatini, M. 2008: Liver echinococcosis in a renal transplant patient: a particularly intriguing case report Journal of Nephrology 21(3): 442-445
Cheymol, G. 1993: Pharmacokinetics and therapeutic monitoring of cyclosporine in liver transplant patients Annales de Gastroenterologie et d'Hepatologie 29(2): 81-85